scholarly journals How to Measure Quality of Life in Integrative Oncology Research

2006 ◽  
Vol 04 (02) ◽  
pp. 100 ◽  
Author(s):  
Andrew J. Vickers
2021 ◽  
Vol 20 ◽  
pp. 153473542110638
Author(s):  
Eun-Bin Kwag ◽  
Soo-Dam Kim ◽  
Ji Hye Park ◽  
So-Jung Park ◽  
Mi-Kyung Jeong ◽  
...  

Cancer is one of the leading causes of death worldwide, and Korea is no exception. Humanity has been fighting cancer for many years, and as a result, we now have effective treatments such as chemotherapy, radiation, and surgery. However, there are other issues that we are only now beginning to address, such as cancer patients’ quality of life. Moreover, numerous studies show that addressing these issues holistically is critical for overall cancer treatment and survival rates. This paper describes how Korea is attempting to reduce cancer incidence and recurrence rates while also managing the quality of life of cancer patients. Integrative Oncology is the field that addresses these broad issues, and understanding the current state of integrative oncology in Korea is critical. The goal of this paper is to provide an overview of the current state of integrative oncology in Korea as well as to look ahead to future developments.


2017 ◽  
Vol 8 (9) ◽  
pp. 1640-1646 ◽  
Author(s):  
Gabriel Lopez ◽  
Wenli Liu ◽  
Jennifer McQuade ◽  
Richard T Lee ◽  
Amy R Spelman ◽  
...  

2021 ◽  
pp. 849-860
Author(s):  
Eran Ben-Arye ◽  
Noah Samuels

Patients with cancer frequently suffer from symptoms related to their disease or its treatment. Many seek out non-conventional medical treatments, often in an alternative setting and with an expectation that ‘natural’ remedies are both safe and effective in providing a ‘cure’ for their disease. While some non-conventional therapies can alleviate symptoms and improve quality of life, they may have adverse effects or herb–drug interactions, compromising treatment outcomes. Many cancer centres today have integrative oncology (IO) services which provide evidence-based guidance on the safe and effective use of complementary and integrative medicine (CIM) for symptom relief, improving quality of life and function. IO settings are headed by integrative physicians, with CIM treatments administered by a multidisciplinary team of medical, paramedical, and non-medical practitioners. CIM treatments are an effective adjunct to conventional supportive and palliative care, using a patient-centred approach to promote trust and better communication between patients and oncology healthcare professionals, including in palliative care. This chapter reviews the current state of IO as it is being provided in the conventional oncology setting, and suggests ways in which further integration can take place. An update on research-based evidence for CIM modalities relevant to palliative care will be presented, with an algorithm-based approach to the implementation of IO in conventional palliative oncology setting.


2015 ◽  
Vol 23 (12) ◽  
pp. 3411-3419 ◽  
Author(s):  
Eran Ben-Arye ◽  
Noah Samuels ◽  
Elad Schiff ◽  
Orit Gressel Raz ◽  
Ilanit Shalom Sharabi ◽  
...  

2006 ◽  
Vol 33 (0) ◽  
pp. 31-36 ◽  
Author(s):  
Kimlin Ashing-Giwa ◽  
Marjorie Kagawa-Singer

2021 ◽  
Vol 28 (4) ◽  
pp. 3150-3171
Author(s):  
Irina Crumpei-Tanasă ◽  
Iulia Crumpei

Psychosocial factors have become central concepts in oncology research. However, their role in the prognosis of the disease is not yet well established. Studies on this subject report contradictory findings. We examine if illness perception and quality of life reports measured at baseline could predict the stress hormones and inflammatory markers in breast cancer survivors, one year later. We use statistics and machine learning methods to analyze our data and find the best prediction model. Patients with stage I to III breast cancer (N = 70) were assessed twice, at baseline and one year later, and completed scales assessing quality of life and illness perception. Blood and urine samples were obtained to measure stress hormones (cortisol and adrenocorticotropic hormone (ACTH) and inflammatory markers (c-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and fibrinogen). Family quality of life is a strong predictor for ACTH. Women who perceive their illness as being more chronic at baseline have higher ESR and fibrinogen values one year later. The artificial intelligence (AI) data analysis yields the highest prediction score of 81.2% for the ACTH stress hormone, and 70% for the inflammatory marker ESR. A chronic timeline, illness control, health and family quality of life were important features associated with the best predictive results.


2021 ◽  
Vol 38 (8) ◽  
Author(s):  
Eran Ben-Arye ◽  
Yonatan Yakubov ◽  
Noah Samuels ◽  
Orit Gressel ◽  
Alexander Yosipovich ◽  
...  

2021 ◽  
Vol 20 ◽  
pp. 153473542110408
Author(s):  
Cristina Rossi ◽  
Claudia Maggiore ◽  
Maria Maddalena Rossi ◽  
Alessio Filippone ◽  
Donatella Guarino ◽  
...  

Background: Breast cancer (BC) survivors have physical and psychological needs that require convincing responses by health care providers. The quality of life issue and clinical unmet needs are among the main reasons pushing a number of patients toward “natural” therapies that are often misleading and alternative to mainstream cancer care. Integrative Oncology (IO) tries to respond to many of those needs, by combining lifestyle counseling, body-mind activities, and complementary evidence-informed therapies with anticancer standard treatments. Methods: In our model at Fondazione Policlinico Gemelli (FPG), every woman diagnosed with a BC waiting for surgery or candidate to neoadjuvant chemotherapy undergoes a preliminary psycho-oncological distress evaluation and a brief lifestyle interview. Anthropometric measurements, body composition analysis, and individual levels of physical activity are recorded. Patients are given evidence based recommendations about the advisable diet and physical activity in a prehabilitation setting. A physician provides patients with information about integrative care plans to treat symptoms related to the disease or its treatments. Therapeutic approaches include acupuncture, mindfulness-based protocols, qigong, massage therapy, and classes of music/art therapy. Results: Between September 2018 and February 2020, the Center for Integrative Oncology at FPG has carried out 1249 lifestyle counseling sessions, 1780 acupuncture treatments, 1340 physiotherapy sessions, 3261 psycho-oncological consultations, 218 herbal medicine counseling sessions. Moreover, 90 BC patients completed the mindfulness based stress reduction (MBSR) protocol and 970 patients participated in qigong, art therapy, and music therapy classes. Conclusions: Our integrative approach aims to achieve a person-centered medicine by improving symptoms management, adherence to oncological protocols, and eventually overall quality of life.


Sign in / Sign up

Export Citation Format

Share Document